Suppr超能文献

细胞质中 p27(Kip1) 的高表达与肾透明细胞癌患者的癌症特异性生存预后较差相关。

High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.

机构信息

Department of Urology Pathology, Eberhard-Karls-University Tuebingen, Tuebingen, Germany.

出版信息

BJU Int. 2012 May;109(10):1565-70. doi: 10.1111/j.1464-410X.2011.10649.x. Epub 2011 Oct 7.

Abstract

UNLABELLED

What's known on the subject? and What does the study add? The loss of p27(Kip1) correlates with poor prognosis in various human cancers, and was postulated as a biomarker in RCC. Up to now p27(Kip1) analysis in RCC was focused on its nuclear localization. We confirmed higher p27(Kip1) expression in the nucleus and cytoplasm of RCC and correlated high cytoplasmic p27(Kip1) with an unfavourable clinic and a reduced survival.

OBJECTIVES

To analyse the cytoplasmic and nuclear differences of p27(Kip1) expression and localization in benign and clear cell renal cell carcinoma (ccRCC) with regard to overall survival (OS) and cancer-specific survival (CSS). p27(Kip1) is considered to contribute to the progression of ccRCC and is targeted by next generation dual-therapies.

PATIENTS AND METHODS

In 140 patients, ccRCC and corresponding benign kidney tissue were analyzed for nuclear and cytoplasmic staining of p27(Kip1) by immunohistochemistry using a tissue microarray technique. Staining intensity and percentage of positive stained cells are given as expression scores. p27(Kip1) expression was categorized as high if ccRCC tissue stained stronger than the respective level of the corresponding benign tissue and categorized as low if ccRCC tissue stained less than or equal to the corresponding benign tissue. Differences in OS and CSS were analyzed by log-rank analysis and expression levels were correlated with tumour and patient characteristics using Fisher's exact test.

RESULTS

Cytoplasmatic (mean [sd]: 13.8% [1.2%] vs 10.7% [1.7%]; P= 0.04) and nuclear (mean [sd]: 75.6% [2.7%] vs 13.6% [2.1%]; P < 0.001) staining of p27(Kip1) were significantly stronger in ccRCC tissues compared to benign tissue. High cytoplasmic p27(Kip1) expression was significantly associated with a higher T and N stage, Fuhrman grade and the presence of metastatic disease (P < 0.001). The median follow-up time was 38.2 months. There was no difference in OS between the low and high expression groups, although CSS was significantly lower in patients with high cytoplasmic p27(Kip1) (P < 0.001) and CSS heavily tended to be lower in the nuclear low expression group (P= 0.069).

CONCLUSIONS

High cytoplasmic p27(Kip1) levels in renal cancer tissues are associated with advanced disease and reduced cancer specific survival, whereas low nuclear expression levels appear to be beneficial. The present study corroborates the consideration of cytoplasmic p27(Kip1) for future diagnostic and targeted therapeutic approaches in RCC establishing a potential protective shift of p27(Kip1) from the cytoplasm to the nucleus.

摘要

目的

分析良性和透明细胞肾细胞癌(ccRCC)中 p27(Kip1)的细胞质和核内差异及其表达与总生存(OS)和癌症特异性生存(CSS)的关系。p27(Kip1)被认为有助于 ccRCC 的进展,并且是下一代双重治疗的靶点。

方法

采用组织微阵列技术,对 140 例 ccRCC 患者及相应的良性肾组织进行 p27(Kip1)核内和细胞质染色的免疫组织化学分析。染色强度和阳性染色细胞的百分比作为表达评分。如果 ccRCC 组织的染色强度强于相应的良性组织水平,则将 p27(Kip1)的表达归类为高,如果 ccRCC 组织的染色强度弱于或等于相应的良性组织,则将 p27(Kip1)的表达归类为低。采用对数秩检验分析 OS 和 CSS 的差异,并采用 Fisher 确切检验将表达水平与肿瘤和患者特征相关联。

结果

与良性组织相比,ccRCC 组织中 p27(Kip1)的细胞质(平均[标准差]:13.8%[1.2%] vs 10.7%[1.7%];P=0.04)和核内(平均[标准差]:75.6%[2.7%] vs 13.6%[2.1%];P<0.001)染色均显著增强。高细胞质 p27(Kip1)表达与更高的 T 和 N 期、Fuhrman 分级和转移性疾病显著相关(P<0.001)。中位随访时间为 38.2 个月。低表达组和高表达组在 OS 方面无差异,尽管 CSS 在高细胞质 p27(Kip1)患者中显著降低(P<0.001),且核内低表达组 CSS 也呈显著降低趋势(P=0.069)。

结论

肾癌细胞组织中高细胞质 p27(Kip1)水平与晚期疾病和降低的癌症特异性生存相关,而核内低表达水平似乎有益。本研究证实了细胞质 p27(Kip1)在 RCC 中未来诊断和靶向治疗方法中的应用,为 p27(Kip1)从细胞质向细胞核的潜在保护转移提供了依据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验